Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing 18F PMPBB3 (APN 1607) PET Imaging, Genetic and Plasma Biomarkers for Risk Identification, Disease Progression and Prognosis of Tauopathy Related Parkinsonism s Yndromes

NCT04557865 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04557865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04557865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing 18F PMPBB3 (APN 1607) PET Imaging, Genetic and Plasma Biomarkers for Risk Identification, Disease Progression and Prognosis of Tauopathy Related Parkinsonism s Yndromes
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2022
Completion date
September 2, 2024
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tau distributions in patients with tauopathy using apn-1607 pet scan